Henry J. Fuchs
2018
Compensation breakdown
| Non-Equity Incentive Plan | $687,925 |
|---|---|
| Option Awards | $1,716,498 |
| Salary | $668,269 |
| Stock Awards | $2,680,926 |
| Other | $24,111 |
| Total | $5,777,729 |
Fuchs received $2.7M in stock awards, accounting for 46% of the total pay in 2018.
Fuchs also received $687.9K in non-equity incentive plan, $1.7M in option awards, $668.3K in salary and $24.1K in other compensation.
Rankings
In 2018, Henry J. Fuchs' compensation ranked 1,646th out of 14,244 executives tracked by ExecPay. In other words, Fuchs earned more than 88.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,646 out of 14,244 | 88th |
Division Manufacturing | 586 out of 5,759 | 90th |
Major group Chemicals And Allied Products | 185 out of 2,122 | 91st |
Industry group Drugs | 147 out of 1,811 | 92nd |
Industry Pharmaceutical Preparations | 108 out of 1,385 | 92nd |
Pay ratio
| Henry J. Fuchs' Pay | $5,777,729 |
|---|---|
| Median Employee's Pay | $160,698 |
| Pay Ratio | 36to 1 |
In 2018, the annual total compensation of Henry J. Fuchs was $5,777,729.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $160,698.
The ratio of Henry J. Fuchs' pay to the pay of median employee was therefore 36 to one.
Fuchs' colleagues
We found five more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2018.
2018
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2018
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2018
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2018
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2018
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019